spacer
MAGAZINE EBOOKS
View digital versions
of our magazines
exactly as they
appear in print





International Clinical Trials
International Clinical Trials
ICT is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.
 
European Pharmaceutical Contractor
European Pharmaceutical Contractor
The EPC edition is designed to fill a unique position in pharmaceutical contractor publishing.
 
European Biopharmaceutical Review
European Biopharmaceutical Review
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
 
Pharmaceutical Manufacturing and Packing Sourcer
Pharmaceutical Manufacturing and Packing Sourcer
PMPS is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
 
Innovations in Pharmaceutical Technology
Innovations in Pharmaceutical Technology
IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies.
 
Features
Evaluating for Market

Achieving Successful Clinical Evaluation Reports

To assess the growing complications in clinical evaluation reports, Dr Efstathios Vassiliadis at Maetrics explores the history of medical device regulations and how to keep on top of a shifting regulatory landscape.
 
Supply and Logistics
Reducing Drug Shortages within the Healthcare Industry

Smarter Supply Chains

Yusen LogisticsEllena Austin and James Colson seek to enhance the supply chain by combatting the many challenges which impede the market process, including limited supply, legislation, and logistical burdens.
 
Neurodegenerative Diseases
Systems Medicine and Drug Repurposing

An Answerable Challenge

Neurodegeneration and neurological disorders as a whole could be considered as the main cause of disability-adjusted years. Dr Hermann Mucke at H.M. Pharma Consultancy encourages the exploration of new drug combinations to drive treatment of such diseases.
 
Anti-Counterfeiting and Serialisation
Implementing Global Standards to Ensure End-to-End GDP Compliance

The Impact of Falsified Medicines

With the arrival of the Falsified Medicines Directive, the impact of this upon pharmaceutical manufacturers should be understood. GS1 UK’s Neil Piper runs through how end-to-end supply chain enhancement can guarantee the authenticity and traceability of medicines.

 

 

Website design and development by Rubler Studio
spacer

Member login

E-mail address:

Password:
Remember me

.
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

.
White Papers

The BioPharmaSpec Approach”: Mass Spectrometry Based Host Cell Protein Identification and Quantitation

BioPharmaSpec

1. Introduction As part of the development of any biopharmaceutical product, the impurities present must be examined, minimized and where possible characterized (1). These impurities fall into two broad categories: product-related impurities (derived specifically from the drug product itself) and process-related impurities (derived from material associated with the production, processing or purification of the sample). Host cell proteins (HCPs) are process-related impurities that require specific analysis due to the multitude of naturally occurring proteins expressed in the production cell line.
More info >>



Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement